» Articles » PMID: 36981484

Detection of Drug-Related Problems Through a Clinical Decision Support System Used by a Clinical Pharmacy Team

Overview
Specialty Health Services
Date 2023 Mar 29
PMID 36981484
Authors
Affiliations
Soon will be listed here.
Abstract

Clinical decision support systems (CDSSs) are intended to detect drug-related problems in real time and might be of value in healthcare institutions with a clinical pharmacy team. The objective was to report the detection of drug-related problems through a CDSS used by an existing clinical pharmacy team over 22 months. It was a retrospective single-center study. A CDSS was integrated in the clinical pharmacy team in July 2019. The investigating clinical pharmacists evaluated the pharmaceutical relevance and physician acceptance rates for critical alerts (i.e., alerts for drug-related problems arising during on-call periods) and noncritical alerts (i.e., prevention alerts arising during the pharmacist's normal work day) from the CDSS. Of the 3612 alerts triggered, 1554 (43.0%) were critical, and 594 of these 1554 (38.2%) prompted a pharmacist intervention. Of the 2058 (57.0%) noncritical alerts, 475 of these 2058 (23.1%) prompted a pharmacist intervention. About two-thirds of the total pharmacist interventions (PI) were accepted by physicians; the proportion was 71.2% for critical alerts (i.e., 19 critical alerts per month vs. 12.5 noncritical alerts per month). Some alerts were pharmaceutically irrelevant-mainly due to poor performance by the CDSS. Our results suggest that a CDSS is a useful decision-support tool for a hospital pharmacist's clinical practice. It can help to prioritize drug-related problems by distinguishing critical and noncritical alerts. However, building an appropriate organizational structure around the CDSS is important for correct operation.

Citing Articles

Can the integration of new rules into a clinical decision support system reduce the incidence of acute kidney injury and hyperkalemia among hospitalized older adults: a protocol for a stepped-wedge, cluster-randomized trial (DETECT-IP).

Payen A, Tlili N, Cousein E, Ferret L, Bozec A, Lenglet A Trials. 2024; 25(1):779.

PMID: 39558377 PMC: 11571581. DOI: 10.1186/s13063-024-08569-w.


Development of explicit definitions of potentially inappropriate prescriptions for antidiabetic drugs in patients with type 2 diabetes: A multidisciplinary qualitative study.

Gerard E, Quindroit P, Calafiore M, Baran J, Gautier S, Genay S PLoS One. 2024; 19(9):e0309290.

PMID: 39331645 PMC: 11432865. DOI: 10.1371/journal.pone.0309290.


One Hundred Explicit Definitions of Potentially Inappropriate Prescriptions of Antibiotics in Hospitalized Older Patients: The Results of an Expert Consensus Study.

Baclet N, Forestier E, Gavazzi G, Roubaud-Baudron C, Hiernard V, Hequette-Ruz R Antibiotics (Basel). 2024; 13(3).

PMID: 38534718 PMC: 10967330. DOI: 10.3390/antibiotics13030283.

References
1.
English D, Ankem K, English K . Acceptance of clinical decision support surveillance technology in the clinical pharmacy. Inform Health Soc Care. 2016; 42(2):135-152. DOI: 10.3109/17538157.2015.1113415. View

2.
Cuvelier E, Robert L, Musy E, Rousseliere C, Marcilly R, Gautier S . The clinical pharmacist's role in enhancing the relevance of a clinical decision support system. Int J Med Inform. 2021; 155:104568. DOI: 10.1016/j.ijmedinf.2021.104568. View

3.
Allenet B, Bedouch P, Rose F, Escofier L, Roubille R, Charpiat B . Validation of an instrument for the documentation of clinical pharmacists' interventions. Pharm World Sci. 2006; 28(4):181-8. DOI: 10.1007/s11096-006-9027-5. View

4.
Yan L, Reese T, Nelson S . A Narrative Review of Clinical Decision Support for Inpatient Clinical Pharmacists. Appl Clin Inform. 2021; 12(2):199-207. PMC: 7968988. DOI: 10.1055/s-0041-1722916. View

5.
Carroll A . Averting Alert Fatigue to Prevent Adverse Drug Reactions. JAMA. 2019; 322(7):601. DOI: 10.1001/jama.2019.11710. View